Qiu, Yao-Ling,Gao, Xuri,Li, Wei,Cao, Hui,Jin, Meizhong,Kass, Jorden,Peng, Xiaowen,Or, Yat Sun
申请号：
AU2017229007
公开号：
AU2017229007A1
申请日:
2017.03.06
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: X-A -Y -L-R (I) which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
